The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs.

Trial Profile

The determination of the exact time of administration of Lantus basal insulin for treating type 2 diabetes mellitus patients poorly controlled with basal insulin associated with oral antidiabetic drugs.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2011

At a glance

  • Drugs Antihyperglycaemics; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LANTUSTITR
  • Sponsors Sanofi
  • Most Recent Events

    • 25 Aug 2011 Additional drug company added in associations field as reported by European Clinical Trials Database record.
    • 28 Jan 2009 Actual patient numbers (4) added as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual initiation date changed from May 2006 to Sep 2006 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top